Related Experiment Videos
The Prentif contraceptive cervical cap: acceptability aspects and their implications for future cap design
Contraception
|February 1, 1982
Summary
The Prentif cervical cap, despite issues like odor and discomfort, showed high user retention. Over 67% of women continued using the contraceptive cap after one year, indicating good acceptability.
Area of Science:
- Gynecology
- Contraception
- Public Health
Background:
- The Prentif cervical cap is a contraceptive device offered in private gynecological practices.
- Previous research has focused on the safety and effectiveness of the Prentif cap.
Purpose of the Study:
- To assess the acceptability of the Prentif cervical cap.
- To identify factors influencing user satisfaction and continued use of the contraceptive cap.
Main Methods:
- A questionnaire was sent to 413 acceptors of the Prentif cervical cap.
- 371 responses were analyzed to gather data on user experiences.
Main Results:
- Key factors reducing acceptability included odor, difficulty with insertion/removal, and partner/self discomfort.
- Attractive features compared to the diaphragm were convenience, safety, spontaneity, and increased libido.
- Despite challenges, 67.4% of users continued using the cap after one year.
Conclusions:
- The Prentif cervical cap demonstrates significant acceptability, even with noted issues.
- Improvements in cap design may address current acceptability challenges.
- Highly motivated users with above-average intelligence contributed to high retention rates.
Keywords:
AmericasBarrier MethodsCervical Cap--side effectsContraceptionContraception Continuation--statisticsContraception TerminationContraceptive AgentsContraceptive Methods--side effectsContraceptive UsageDeveloped CountriesEconomic FactorsEvaluationEvaluation IndexesFamily PlanningMethod AcceptabilityNorth AmericaNorthern AmericaQuantitative EvaluationResearch And DevelopmentSex BehaviorSpermicidal Contraceptive AgentsTechnologyUnited StatesVaginaVaginal Barrier Methods--side effectsVaginal CreamVaginal Spermicides